Effect of glucocorticoids on fetal immunoglobulin production after premature rupture of membranes.
Cord blood IgA and IgM levels were measured in newborns of mothers with prematurely ruptured membranes (PRM) who had also received prenatal glucocorticoid treatment to accelerate fetal lung maturity. Previous data show that some newborns of mothers with PRM had elevated IgA and/or IgM levels. This increase was also found in the present glucocorticoid-treated group, indicating that glucocorticoid therapy did not appear to alter fetal humoral immune response at all.
D001623:Betamethasone / Q000494:pharmacology*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000276:immunology*; D005333:Fetus / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000096:biosynthesis; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis; D007136:Immunoglobulins / Q000096:biosynthesis*; D007231:Infant, Newborn; D008168:Lung / Q000196:embryology; D008431:Maternal-Fetal Exchange; D011247:Pregnancy
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D001623:Betamethasone